Exogenous cofactors for the improvement of bioremoval and biotransformation of sulfamethoxazole by Alcaligenes faecalis

Science of the Total Environment

Volumn 565, Issue , 2016, Pages 547-556

  Zhang, Yi Bi ^a,b,c   Zhou, Jiao ^a,b,c   Xu, Qiu Man ^d   Cheng, Jing Sheng ^a,b,c   Luo, Yu Lu ^a,b,c   Yuan, Ying Jin ^a,b,c  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b TIANJIN UNIVERSITY   (China)

^c SynBio Research Platform   (China)

^d TIANJIN NORMAL UNIVERSITY   (China)

Author keywords

Antibiotics; Biotransformation; Cofactor; Removal; Sulfamethoxazole

Indexed keywords

AMIDES; ANTIBIOTICS; BIODEGRADATION; BIOMASS; EFFICIENCY; NUCLEOTIDES; PEPTIDES; REMOVAL;

BIOTRANSFORMATION; COFACTORS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHS; NICOTINAMIDE ADENINE DINUCLEOTIDES; PHARMACEUTICAL PRODUCTS; SULFAMETHOXAZOLE; SULFAMETHOXAZOLE (SMX); TRANSFORMATION PRODUCTS;

BIOCONVERSION;

SULFAMETHOXAZOLE; ANTIINFECTIVE AGENT;

ANTIBIOTICS; BACTERIUM; BIODEGRADATION; BIOTRANSFORMATION; POLLUTANT REMOVAL;

ALCALIGENES FAECALIS; AQUATIC ENVIRONMENT; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BIODEGRADATION; BIOMASS; BIOTRANSFORMATION; CONCENTRATION RESPONSE; CORRELATION ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMEOSTASIS; INCUBATION TIME; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; BIOREMEDIATION; GROWTH, DEVELOPMENT AND AGING; MASS SPECTROMETRY; METABOLISM; WATER POLLUTANT;

ALCALIGENES FAECALIS;

ALCALIGENES FAECALIS; ANTI-BACTERIAL AGENTS; BIODEGRADATION, ENVIRONMENTAL; BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; MASS SPECTROMETRY; SULFAMETHOXAZOLE; WATER POLLUTANTS, CHEMICAL;

EID: 84966714499     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2016.05.063     Document Type: Article

References (56)

1. Alvarino T., Nastold P., Suarez S., Omil F., Corvini P.F., Bouju H. Role of biotransformation, sorption and mineralization of (14)C-labelled sulfamethoxazole under different redox conditions. Sci. Total Environ. 2016, 542(Pt A):706-715. 10.1016/j.scitotenv.2015.10.140.
2. Aydin S., Ince B., Ince O. Inhibitory effect of erythromycin, tetracycline and sulfamethoxazole antibiotics on anaerobic treatment of a pharmaceutical wastewater. Water Sci. Technol. 2015, 71(11):1620-1628. 10.2166/wst.2015.126.
3. Barber L.B., Keefe S.H., Leblanc D.R., Bradley P.M., Chapelle F.H., Meyer M.T., Loftin K.A., Kolpin D.W., Rubio F. Fate of sulfamethoxazole, 4-nonylphenol, and 17beta-estradiol in groundwater contaminated by wastewater treatment plant effluent. Environ. Sci. Technol. 2009, 43(13):4843-4850. 10.1021/es803292v.
4. Berríos-Rivera S.J., Bennett G.N., San K.Y. Metabolic engineering of Escherichia coli: increase of NADH availability by overexpressing an NAD(+)-dependent formate dehydrogenase. Metab. Eng. 2002, 4(3):217-229. 10.1006/mben.2002.0227.
5. Bhusari S., Abouraya M., Padilla M.L., Pinkerton M.E., Drescher N.J., Sacco J.C., Trepanier L.A. Combined ascorbate and glutathione deficiency leads to decreased cytochrome b5 expression and impaired reduction of sulfamethoxazole hydroxylamine. Arch. Toxicol. 2010, 84(8):597-607. 10.1007/s00204-010-0530-z.
6. Bouju H., Ricken B., Beffa T., Corvini P.F., Kolvenbach B.A. Isolation of bacterial strains capable of sulfamethoxazole mineralization from an acclimated membrane bioreactor. Appl. Environ. Microbiol. 2012, 78(1):277-279. 10.1128/AEM.05888-11.
7. Burkhart C., von Greyerz S., Depta J.P., Naisbitt D.J., Britschgi M., Park K.B., Pichler W.J. Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole-metabolite-specific human CD4+ T-cells. Br. J. Pharmacol. 2001, 132(3):623-630. 10.1038/sj.bjp.0703845.
8. Cetecioglu Z. Aerobic inhibition assessment for anaerobic treatment effluent of antibiotic production wastewater. Environ. Sci. Pollut. Res. Int. 2014, 21(4):2856-2864. 10.1007/s11356-013-2243-3.
9. Chang J.S. Biotransformation of arsenite and bacterial aox activity in drinking water produced from surface water of floating houses: arsenic contamination in Cambodia. Environ. Pollut. 2015, 206:315-323. 10.1016/j.envpol.2015.07.027.
10. Christen P., Mehta P.K. From cofactor to enzymes. The molecular evolution of pyridoxal-5'-phosphate-dependent enzymes. Chem. Rec. 2001, 1(6):436-447. 10.1002/9780470123201.ch4.
11. Cruz-Morató C., Lucas D., Llorca M., Rodriguez-Mozaz S., Gorga M., Petrovic M., Barceló D., Vicent T., Sarrà M., Marco-Urrea E. Hospital wastewater treatment by fungal bioreactor: removal efficiency for pharmaceuticals and endocrine disruptor compounds. Sci. Total Environ. 2014, 493:365-376. 10.1016/j.scitotenv.2014.05.117.
12. Dai J.J., Cheng J.S., Liang Y.Q., Jiang T., Yuan Y.J. Regulation of extracellular oxidoreduction potential enhanced (R,R)-2,3-butanediol production by Paenibacillus polymyxa CJX518. Bioresour. Technol. 2014, 167:433-440. 10.1016/j.biortech.2014.06.044.
13. Deng Y., Li B., Yu K., Zhang T. Biotransformation and adsorption of pharmaceutical and personal care products by activated sludge after correcting matrix effects. Sci. Total Environ. 2016, 544:980-986. 10.1016/j.scitotenv.2015.12.010.
14. Ebert B.E., Kurth F., Grund M., Blank L.M., Schmid A. Response of pseudomonas putida KT2440 to increased NADH and ATP demand. Appl. Environ. Microbiol. 2011, 77(18):6597-6605. 10.1128/AEM.05588-11.
15. Fernandez-Fontaina E., Gomes I.B., Aga D.S., Omil F., Lema J.M., Carballa M. Biotransformation of pharmaceuticals under nitrification, nitratation and heterotrophic conditions. Sci. Total Environ. 2016, 541:1439-1447. 10.1016/j.scitotenv.2015.10.010.
16. Fischer J.D., Holliday G.L., Rahman S.A., Thornton J.M. The structures and physicochemical properties of organic cofactors in biocatalysis. J. Mol. Biol. 2010, 403(5):803-824. 10.1016/j.jmb.2010.09.018.
17. Gao P., Mao D., Luo Y., Wang L., Xu B., Xu L. Occurrence of sulfonamide and tetracycline-resistant bacteria and resistance genes in aquaculture environment. Water Res. 2012, 46(7):2355-2364. 10.1016/j.watres.2012.02.004.
18. García-Galán M.J., Díaz-Cruz M., Barceló D. Identification and determination of metabolites and degradation products of sulfonamide antibiotics. Trends Anal. Chem. 2008, 27(11):1008-1022. 10.1016/j.trac.2008.10.001.
19. García-Galán M.J., González Blanco S., López Roldán R., Díaz-Cruz S., Barceló D. Ecotoxicity evaluation and removal of sulfonamides and their acetylated metabolites during conventional wastewater treatment. Sci. Total Environ. 2012, 437:403-412. 10.1016/j.scitotenv.2012.08.038.
20. Gauthier H., Yargeau V., Cooper D.G. Biodegradation of pharmaceuticals by Rhodococcus rhodochrous and Aspergillus niger by co-metabolism. Sci. Total Environ. 2010, 408:1701-1706. 10.1016/j.scitotenv.2009.12.012.
21. Islas-Espinoza M., Reid B.J., Wexler M., Bond P.L. Soil bacterial consortia and previous exposure enhance the biodegradation of sulfonamides from pig manure. Microb. Ecol. 2012, 64(1):140-151. 10.1007/s00248-012-0010-5.
22. Jiang Y., Wen J., Bai J., Jia X., Hu Z. Biodegradation of phenol at high initial concentration by Alcaligenes faecalis. J. Hazard. Mater. 2007, 147(1-2):672-676. 10.1016/j.jhazmat.2007.05.031.
23. Jiang B., Li A., Cui D., Cai R., Ma F., Wang Y. Biodegradation and metabolic pathway of sulfamethoxazole by Pseudomonas psychrophila HA-4, a newly isolated cold-adapted sulfamethoxazole-degrading bacterium. Appl. Microbiol. Biotechnol. 2014, 98(10):4671-4681. 10.1007/s00253-013-5488-3.
24. Kagaya H., Miura M., Niioka T., Saito M., Numakura K., Habuchi T., Satoh S. Influence of NAT2 polymorphisms on sulfamethoxazole pharmacokinetics in renal transplant recipients. Antimicrob. Agents Chemother. 2012, 56(2):825-829. 10.1128/AAC.05037-11.
25. Kim S.C., Carlson K. Temporal and spatial trends in the occurrence of human and veterinary antibiotics in aqueous and river sediment matrices. Environ. Sci. Technol. 2007, 41(1):50-57. 10.1021/es060737+.
26. Larcher S., Yargeau V. Biodegradation of sulfamethoxazole by individual and mixed bacteria. Appl. Microbiol. Biotechnol. 2011, 91(1):211-218. 10.1007/s00253-011-3257-8.
27. Lavergne S.N., Kurian J.R., Bajad S.U., Maki J.E., Yoder A.R., Guzinski M.V., Graziano F.M., Trepanier L.A. Roles of endogenous ascorbate and glutathione in the cellular reduction and cytotoxicity of sulfamethoxazole-nitroso. Toxicology 2006, 222(1-2):25-36. 10.1016/j.tox.2006.01.018.
28. Mailler R., Gasperi J., Coquet Y., Buleté A., Vulliet E., Deshayes S., Zedek S., Mirande-Bret C., Eudes V., Bressy A., Caupos E., Moilleron R., Chebbo G., Rocher V. Removal of a wide range of emerging pollutants from wastewater treatment plant discharges by micro-grain activated carbon in fluidized bed as tertiary treatment at large pilot scale. Sci. Total Environ. 2016, 542(Pt A):983-996. 10.1016/j.scitotenv.2015.10.153.
29. Marx C., Günther N., Schubert S., Oertel R., Ahnert M., Krebs P., Kuehn V. Mass flow of antibiotics in a wastewater treatment plant focusing on removal variations due to operational parameters. Sci. Total Environ. 2015, 538:779-788. 10.1016/j.scitotenv.2015.08.112.
30. Masip L., Veeravalli K., Georgiou G. The many faces of glutathione in bacteria. Antioxid. Redox Signal. 2006, 8(5-6):753-762. 10.1089/ars.2006.8.753.
31. Men Y., Seth E.C., Yi S., Allen R.H., Taga M.E., Alvarez-Cohen L. Sustainable growth of Dehalococcoides mccartyi 195 by corrinoid salvaging and remodeling in defined lactate-fermenting consortia. Appl. Environ. Microbiol. 2014, 80(7):2133-2141. 10.1128/AEM.03477-13.
32. Muller M., Merrett N.D. Mechanism for glutathione-mediated protection against the Pseudomonas aeruginosa redox toxin, pyocyanin. Chem. Biol. Interact. 2015, 232:30-37. 10.1016/j.cbi.2015.03.011.
33. Naisbitt D.J., Hough S.J., Gill H.J., Pirmohamed M., Kitteringham N.R., Park B.K. Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity. Br. J. Pharmacol. 1999, 126(6):1393-1407. 10.1038/sj.bjp.0702453.
34. Neerackal G.M., Ndegwa P.M., Joo H.S., Wang X., Frear C.S., Harrison J.H., Beutel M.W. Potential application of Alcaligenes faecalis strain no. 4 in mitigating ammonia emissions from dairy wastewater. Bioresour. Technol. 2016, 206:36-42. 10.1016/j.biortech.2016.01.063.
35. Nie X.P., Liu B.Y., Yu H.J., Liu W.Q., Yang Y.F. Toxic effects of erythromycin, ciprofloxacin and sulfamethoxazole exposure to the antioxidant system in Pseudokirchneriella subcapitata. Environ. Pollut. 2013, 172:23-32. 10.1016/j.envpol.2012.08.013.
36. Osorio V., Sanchís J., Abad J.L., Ginebreda A., Farré M., Pérez S., Barceló D. Investigating the formation and toxicity of nitrogen transformation products of diclofenac and sulfamethoxazole in wastewater treatment plants. J. Hazard. Mater. 2016, 309:157-164. 10.1016/j.jhazmat.2016.02.013.
37. Ott G., Plitzko B., Krischkowski C., Reichmann D., Bittner F., Mendel R.R., Kunze T., Clement B., Havemeyer A. Reduction of sulfamethoxazole hydroxylamine (SMX-HA) by the mitochondrial amidoxime reducing component (mARC). Chem. Res. Toxicol. 2014, 27(10):1687-1695. 10.1021/tx500174u.
38. Pallotta M.L. Evidence for the presence of a FAD pyrophosphatase and a FMN phosphohydrolase in yeast mitochondria: a possible role in flavin homeostasis. Yeast 2011, 28(10):693-705. 10.1002/yea.1897.
39. Paredes L., Fernandez-Fontaina E., Lema J.M., Omil F., Carballa M. Understanding the fate of organic micropollutants in sand and granular activated carbon biofiltration systems. Sci. Total Environ. 2016, 551-552:640-648. 10.1016/j.scitotenv.2016.02.008.
40. Radke M., Lauwigi C., Heinkele G., Mürdter T.E., Letzel M. Fate of the antibiotic sulfamethoxazole and its two major human metabolites in a water sediment. Environ. Sci. Technol. 2009, 43(9):3135-3141. 10.1021/es900300u.
41. Ramaswamy J., Prasher S.O., Patel R.M., Hussain S.A., Barrington S.F. The effect of composting on the degradation of a veterinary pharmaceutical. Bioresour. Technol. 2010, 101(7):2294-2299. 10.1016/j.biortech.2009.10.089.
42. Rébeillé F., Ravanel S., Marquet A., Mendel R.R., Webb M.E., Smith A.G., Warren M.J. Roles of vitamins B5, B8, B9, B12 and molybdenum cofactor at cellular and organismal levels. Nat. Prod. Rep. 2007, 24(5):949-962. 10.1016/j.biortech.2009.10.089.
43. Reis P.J., Reis A.C., Ricken B., Kolvenbach B.A., Manaia C.M., Corvini P.F., Nunes O.C. Biodegradation of sulfamethoxazole and other sulfonamides by Achromobacter denitrificans PR1. J. Hazard. Mater. 2014, 280:741-749. 10.1016/j.jhazmat.2014.08.039.
44. Ricken B., Corvini P.F., Cichocka D., Parisi M., Lenz M., Wyss D., Martínez-Lavanchy P.M., Müller J.A., Shahgaldian P., Tulli L.G., Kohler H.P., Kolvenbach B.A. Ipso-hydroxylation and subsequent fragmentation: a novel microbial strategy to eliminate sulfonamide antibiotics. Appl. Environ. Microbiol. 2013, 79(18):5550-5558. 10.1128/AEM.00911-13.
45. Roychowdhury S., Vyas P.M., Reilly T.P., Gaspari A.A., Svensson C.K. Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes. J. Pharmacol. Exp. Ther. 2005, 314(1):43-52. 10.1124/jpet.105.086009.
46. Schwarzenbach R.P., Egli T., Hofstetter T.B., von Gunten U., Wehrli1 B. Global water pollution and human health. Annu. Rev. Environ. Resour. 2010, 35:109-136. 10.1146/annurev-environ-100809-125342.
47. Stadler L.B., Su L., Moline C.J., Ernstoff A.S., Aga D.S., Love N.G. Effect of redox conditions on pharmaceutical loss during biological wastewater treatment using sequencing batch reactors. J. Hazard. Mater. 2015, 282:106-115. 10.1016/j.jhazmat.2014.08.002.
48. Straub J.O. Aquatic environmental risk assessment for human use of the old antibiotic sulfamethoxazole in Europe. Environ. Toxicol. Chem. 2015, 9999:1-13. 10.1002/etc.2945.
49. Underwood J.C., Harvey R.W., Metge D.W., Repert D.A., Baumgartner L.K., Smith R.L., Roane T.M., Barber L.B. Effects of the antimicrobial sulfamethoxazole on groundwater bacterial enrichment. Environ. Sci. Technol. 2011, 45(7):3096-3101. 10.1021/es103605e.
50. van der Ven A.J., Vree T.B., van Ewijk-Beneken Kolmer E.W., Koopmans P.P., van der Meer J.W. Urinary recovery and kinetics of sulphamethoxazole and its metabolites in HIV-seropositive patients and healthy volunteers after a single oral dose of sulphamethoxazole. Br. J. Clin. Pharmacol. 1995, 39(6):621-625. 10.1021/es103605e.
51. Wang Y., San K.Y., Bennett G.N. Cofactor engineering for advancing chemical biotechnology. Curr. Opin. Biotechnol. 2013, 24(6):994-999. 10.1016/j.copbio.2013.03.022.
52. Winter H.R., Unadkat J.D. Identification of cytochrome P450 and arylamine N-acetyltransferase isoforms involved in sulfadiazine metabolism. Drug Metab. Dispos. 2005, 33(7):969-976. 10.1124/dmd.104.002998.
53. Yang C.W., Hsiao W.C., Chang B.V. Biodegradation of sulfonamide antibiotics in sludge. Chemosphere 2016, 150:559-565. 10.1016/j.chemosphere.2016.02.064.
54. Yargeau V., Huot J.C., Rodayan A., Rouleau L., Roy R., Leask R.L. Impact of degradation products of sulfamethoxazole on mammalian cultured cells. Environ. Toxicol. 2008, 23(4):492-498. 10.1002/tox.20368.
55. Zhang Q.Q., Ying G.G., Pan C.G., Liu Y.S., Zhao J.L. Comprehensive evaluation of antibiotics emission and fate in the river basins of China: source analysis, multimedia modeling, and linkage to bacterial resistance. Environ. Sci. Technol. 2015, 49(11):6772-6782. 10.1021/acs.est.5b00729.
56. Zhou L.J., Ying G.G., Liu S., Zhao J.L., Yang B., Chen Z.F., Lai H.J. Occurrence and fate of eleven classes of antibiotics in two typical wastewater treatment plants in South China. Sci. Total Environ. 2013, 452-453:365-376. 10.1016/j.scitotenv.2013.03.010.